Kiniksa Pharmaceuticals
Price & Volume
Stats
See more52W Range | $17.82-$39.43 |
Market Cap | $2.8B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $529.3M |
Revenue Growth (YoY) | 44.3% |
Gross Profit (12 Mos) | $281.1M |
Diluted EPS | $0.05 |
News
See moreYahoo Finance • 25 days ago
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
Yahoo Finance • last month
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Yahoo Finance • 2 months ago
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential
Yahoo Finance • 2 months ago
KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout
About
CEO | Mr. Sanj K. Patel |
CFO | Mr. Mark A. Ragosa C.F.A. |
Address | 23 Old Bond Street, London, United Kingdom, WIS 4PZ |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 315 |
